Sign In
Buy BXRX
$0.0218
+0 (+0%)
At Close: May 28, 2024
The Daily Biotech Pulse: T2 Biosystems Licenses COVID-19 Test, Immuron CEO Steps Down
11:29am, Wednesday, 25'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 24) * BELLUS Health Inc (NASDAQ: BLU) * Global Cord
Baudax Bio Announces Pricing of Public Offering of Common Stock and Warrants
01:15pm, Tuesday, 24'th Mar 2020
Baudax Bio, Inc. (“Baudax” or the “Company”) (BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced the pricing of an underwritten public offering of
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 23.) * Arcutis Biotherapeutics Inc (NASDAQ: ARQT) * Be
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 23.)
Arcutis Biotherapeutics...
5 Stocks Moving In Monday's After-Hours Session
08:42pm, Monday, 23'rd Mar 2020
Gainers
Gilead Sciences (NASDAQ: GILD) shares are trading higher as traders circulate word that the company received FDA Orphan Drug Designation for Remdesivir as a...
Baudax Bio Announces Proposed Public Offering of Common Stock and Warrants
08:20pm, Monday, 23'rd Mar 2020
Baudax Bio, Inc. (“Baudax” or the “Company”) (BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced that it has commenced an underwritten public offe
Baudax Bio Signs Non-Binding Term Sheet for Debt Facility
04:43pm, Wednesday, 04'th Mar 2020
MALVERN, Pa., March 04, 2020 -- Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced that, as part of its.
Attention Biotech Investors: Mark Your Calendar For These March PDUFA Dates
09:46pm, Monday, 02'nd Mar 2020
Biotech stocks came under selling pressure in February, although the degree of weakness was not as worse as the broader market, thanks to strong upward moves by stocks that are levered to COVID-19 epi
S, DE among premarket gainers
02:24pm, Friday, 21'st Feb 2020
DPW Holdings (NYSEMKT:DPW) +38% after defense unit gets $1.4M follow-on order.California Resources (NYSE:CRC) +26% on exchange offers and subscriptions.Baudax Bio (NASDAQ:BXRX) +23% on FDA nod
The Daily Biotech Pulse: FDA Approves Baudax Bio's Non-Opioid Pain Drug, Aerie Rallies On Q4 Results, D-Day For Esperion
12:46pm, Friday, 21'st Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on Feb. 20.) Akebia Therapeutics Inc (NASDAQ: AKBA ) Aptose B
33 Stocks Moving in Friday's Pre-Market Session
12:15pm, Friday, 21'st Feb 2020
Gainers
Baudax Bio, Inc. (NASDAQ: BXRX) shares rose 30% to $10.40 in pre-market trading after the company reported the FDA approval of ANJESO for management of moderate to...
Baudax Bio Announces FDA Approval of ANJESO™ for the Management of Moderate to Severe Pain
09:05pm, Thursday, 20'th Feb 2020
ANJESO Is The Only Approved 24-Hour, Intravenous COX-2 Preferential NSAID that Offers Once-Daily Dosing U.S. Commercial Launch Planned to Commence in Late April or Early May.
The Daily Biotech Pulse: Heron Pain Drug Review Extended, Disappointment For Teva In Tourette Syndrome Study
12:06pm, Thursday, 20'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 19) Adverum Biotechnologies Inc (NASDAQ: ADVM ) Akebia
3 “Strong Buy” Healthcare Stocks With Fast-Approaching Catalysts
11:16pm, Wednesday, 19'th Feb 2020
Healthcare stocks have a reputation of keeping investors on their toes. The possibility of surging price action, or conversely, earth shattering drops is very real, but these movements can come and go
The Week Ahead In Biotech: Agile, Baudax Bio, Merck and Esperion Await FDA Decisions
08:03pm, Sunday, 16'th Feb 2020
Biotech stocks were quiet in the week ending Feb. 14 amid some data readouts at a couple of conferences and earnings news flow from smid-cap companies. The following are key biotech catalysts to loo
